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Introduction 
Substance abuse disorders incur a significant cost to global judicial and 
healthcare systems (Lynskey & Strang, 2013). Addiction is loosely defined 
as a chronic relapsing spectrum disorder characterized by a loss of control 
over substance use (Girard & Carlton, 1978; Goodman, 1990; Peele, 1977). 
It is a behavior-based phenomenon representing a diverse array of 
psychological, biological, and genetic attributes, along with environmental 
and cultural factors (Goodwin, 1975; Naranjo & Bremner, 1993; Truan, 
1993). Additionally, individuals addicted to illicit substances are stigmatized, 
with a widespread marginalization of rehabilitation and recovery services 
that perhaps facilitates recidivism (Cunningham, Sobell, & Chow, 1993; 
Dean & Rud, 1984; Room, 2005). The current standard of care for 
individuals attempting to overcome addiction behaviors emphasizes 
complete abstinence from addictive substances, and to a lesser extent 
treatment (Hoffman & Goldfrank, 1990; Lorman, 2013).  
A large number of studies, including genome-wide association 
investigations, have uncovered potentially relevant allelic contributors to the 
genetic and molecular basis of addiction phenotypes (Kreek, Nielsen, & 
LaForge, 2004; Le Foll, Gallo, Le Strat, Lu, & Gorwood, 2009; Messer et 
al., 2000; Olfson & Bierut, 2012; Popendikyte et al., 1999; Shi et al., 2002; 
Treutlein & Rietschel, 2011). Genetic studies such as those conducted on 
the alcohol dehydrogenase gene (ADH) family have been important for 
advancing our understanding of the genetic basis of addiction phenotypes 
(Crabb, Bosron, & Li, 1987; Pietruszko, 1975). The literature describes two 
main molecular areas underlying addiction phenotypes. The first is 
analyzed at the level of neurological function (Chao & Nestler, 2004; 
Gardner, 2011; Maldonado, 2003). Disruption of the normal range of 
neurological function has been well characterized both in the literature and 
in the canonical metabolic pathways that have been identified as 
participating in addictions such as alcohol, cocaine, and dopaminergic 
substance abuse (Commons, 2010; Hillemacher, 2011; Sun & Zhao, 2010). 
The second is addressed at the level of metabolic function (Chiang, Lo, & 
Chen, 2013), such as characterization of the ADH gene family and its 
function in the metabolism of alcohol products (Cotton & Goldman, 1988; 
Ehlers, Liang, & Gizer, 2012). 
Association studies are yet to provide a complete picture for 
elucidating the complex pathways and mechanisms underlying addiction 
phenotypes. The population subtype–dependent mechanisms of addiction 
have not been fully explored  (Pasche & Yi, 2010; Uhl et al., 2008; Yuferov, 
Levran, Proudnikov, Nielsen, & Kreek, 2010), and neither have the 
epigenetic factors involved in addiction (Petronis, 2010; Ponomarev, 2013; 
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Schumacher & Petronis, 2006; R. Zhang et al., 2013). Because the tissues 
involved in addiction, particularly neurons and liver tissue, cannot be 
experimentally investigated in humans, experiments in animal models and 
in vitro experiments have been used to quantify epigenetic, transcriptomic, 
metabolomic, and proteomic changes in addiction-perturbed tissues 
(Adkins et al., 2013; Brown et al., 2012; Contet, 2012; Freeman et al., 2005; 
Lee & Messing, 2008; K. W. Li et al., 2006; Mulligan et al., 2006; Saito et 
al., 2004; G. C. Zhang et al., 2009). This has limited our ability to understand 
how addiction gene variation plays out in the geographically and ethnically 
diverse human populations that are afflicted by addiction disorders. 
Studying a diverse array of ethnic populations that represent major human 
geographical regions and ancestries would be particularly useful in 
understanding the role that variation plays at potential addiction complex 
sites in the genome.  
Opiate, dopamine, and gamma aminobutyric acid (GABA) addictions 
are complex diseases with strong genetic components. Addiction to opioids, 
amphetamines, and alcohol arise owing to a complex array of social, 
genetic, and environmental factors. This paper demonstrates a 
comprehensive computational approach to incorporating biological data 
sets to address addiction in ethnic minority populations. Combining these 
biological data types both identifies novel, functionally relevant genetic 
variants for addiction and informs the conditions under which these variants 
are correlated to addiction phenotypes.  
 
Methods 
Addiction-Linked Genes and Genome Hotspots 
The National Center for Biotechnology Information (NCBI) Gene database 
was queried according to the word combinations shown in Figure 1 to 
generate a list of genes with biological relevance to dopamine (cocaine and 
crystal methamphetamine), opiate (heroine and morphine), and GABA 
(alcohol and gamma hydroxybutyrate [GHB]) addiction phenotypes. This 
unique set of genes was then mapped onto human chromosomes, and 
clusters of genes were considered (Blankenberg et al., 2010; Giardine et 
al., 2005; Goecks, Nekrutenko, Taylor, & Galaxy, 2010). Browser 
Extensible Data (BED) output files were used to visualize the hotspot genes 
on the University of California, Santa Cruz (UCSC) Genome Browser as a 
custom track within the HG-19 human genome build.  
Hotspots were defined as genic regions of approximately 1.0 to 1.5 
Mb, corresponding to a human centiMorgan unit of recombination, in 
physical distance along the genome that contained six or more genes 
identified from our combined addiction gene list. Each hotspot contained 
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genes not currently associated with addiction phenotypes. We included 
such genes into our analysis because of the high probability of common 
regulation patterns within a hotspot. Next, we investigated the statistical 
significance of observing six or more genes as hotspots by using the 
hypergeometric test statistic for chromosomal hotspot gene enrichment.  
 
Functional Annotation of Hotspot Genes 
Genes located within hotspots were considered in two ways in statistical 
enrichments: all genes in the hotspot window and only those previously 
linked to addiction. All genes in the hotspots were annotated with tools in 
the DAVID (Database for Annotation, Visualization, and Integrated 
Discovery) Bioinformatics Resources software (Huang da, Sherman, & 
Lempicki, 2009; Huang da et al., 2009) for biological process, molecular 
function, and KEGG (Kyoto Encyclopedia of Genes and Genomes) 
pathways (Kanehisa, 2002; Kanehisa, Goto, Kawashima, & Nakaya, 2002). 
Functional enrichments were quantified with Benjamini score analysis 
cutoffs of 0.01 (Benjamini, Drai, Elmer, Kafkafi, & Golani, 2001). A MATLAB 
code was written to multicolor the nodes in KEGG pathways to differentiate 
between genes belonging to different hotspots. 
 
Genetic Variation in Hotspots in Population Subtypes 
We examined hotspot-associated polymorphisms identified in 11 HapMap 
sample populations with distinct geographical distributions. These were 
East Asian ancestry [Japanese-JPT, Chinese (collected in Beijing)-CHB, 
Chinese (collected in Denver)-CHD]; African ancestry [Yorubans-YRI, 
Masaai-MKK, Luhya-LWK, and African Americans-ASW]; European 
ancestry [Europeans of Northern and Western Ancestry-CEU and Toscana-
TSI]; South Asian ancestry [Gujaratis in Houston-GIH]; and an admixed 
American population [Mexicans in Los Angeles-MEX] (International 
HapMap Consortium, 2005; International HapMap Consortium et al., 2010; 
International HapMap Consortium et al., 2007). To exclude the possibility of 
confounding effects of population-specific demography and to set up an 
empirically derived neutral estimate of allelic variation, we analyzed 20 
concatenated autosomal loci across the human genome identified as 
neutrally evolving (Wall et al., 2008). It was assumed that polymorphism 
variation undergoing selection will have patterns divergent from neutral 
allele frequency patterns. Single-nucleotide polymorphism (SNP) 
frequencies were trimmed to exclude SNPs that were almost fixed in 
populations (>0.9) or of low frequency (<0.15). Average SNP frequencies 
were calculated across the window and compared in all populations. The 
Kolmogorov-Smirnov test (Fuerst, Chakraborty, & Nei, 1977) was 
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performed to test for pairwise differences in the distributions of 
polymorphism profiles between populations at the concatenated neutral 
region and all addiction hotspots. Populations were clustered by regional 
ethnic origin: Africans [Luhya (LWK), Masaai (MKK), Yorubans (YRI), and 
African Americans (ASW)]; Asians [Chinese-Beijing (CHB), Chinese-
Denver (CHD), and Japanese (JPT)]; and Europeans [Western Europeans 
(CEU) and Toscana (TSI)].  
Populations with similar geographical ethnic origins were 
concatenated by continent of origin and then compared [African (ASW, YRI, 
MKK, LWK) with European (CEU, TSI); African with Asian (CHB, CHD, 
JPT); and European with Asian] in order to conduct pairwise assessments 
of significantly different polymorphisms; a chi-square test was used to test 
the divergence of the frequency ratios from 1. Significant polymorphisms 
were then annotated by their genomic location as coding, intronic, or 
intergenic polymorphisms. These significantly different polymorphisms 
were compared with known genotype-phenotype associations by using 
GWAS3D, a web-based software program that identifies Genome-Wide 
Association Study (GWAS) Central regulatory elements for long-range 
linkage and cross-chromosome interactions (M. J. Li, Wang, Xia, Sham, & 
Wang, 2013). 
 
Results 
Molecular Functions and Biological Processes of Addiction Genes 
A list of biologically relevant genes was generated from searches with NCBI 
Gene with phenotypic relationships to opiate, dopamine, and GABA 
addiction. Three classes of addiction genes were thus obtained: dopamine 
addiction genes (N=108), opiate addiction genes, (N=246) and GABA 
addiction genes (N=433). Because addiction can arise from substance 
abuse or misregulation of metabolism, search terms were categorized as 
either “metabolism” (N=398 genes) or “addiction” (N=461 genes) followed 
by the names of three addictive substances: dopamine, opiate, and GABA 
receptor. The respective heat maps in Figure 1 illustrate the intersections 
within the search terms for both the metabolism and the addiction gene lists. 
Additionally, we compared our gene list with the one reported by C. Y. Li, 
Mao, & Wei (2008), which contains 387 genes involved in four addiction 
disorders. This comparison is shown in a Venn diagram, with the majority 
of genes (N=311) not identified in our analysis belonging to nicotine 
addiction, a disorder not addressed here. A set of unique addiction genes 
(N=587), compiled from the union of all search terms, was thus determined.  
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Figure 1. Flowchart for identifying biologically relevant addiction genes. The search 
terms used at NCBI Gene to populate a list of unique addiction genes are shown. The 
heat maps indicate the intersection of gene sets in three classes of addiction: dopamine, 
opiate, and GABA. Addiction hotspots were defined as a genomic region with six or more 
addiction genes within a 1- to 1.5-Mb genomic window. A Venn diagram shows the 
comparison with the 387 genes identified through an alternate addiction study (C. Y. Li et 
al., 2008).  
 
Figure 2 illustrates the overlap in the opiate, dopamine, and GABA 
gene sets. Roughly 10% of addiction genes were shared among all 
addiction types (N=51 genes). This subset included leucine zipper family of 
DNA binding proteins, genes that code for glutamate-gated ion channels, 
and sodium:neurotransmitter symporters. Annotation of the overlapping 
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sets of genes for dopamine, opiates, and GABA indicate that these 
literature-curated addiction genes are involved in diverse processes 
underlying addictive xenobiotic metabolism. 
 
 
Figure 2. Genes shared by dopamine, opiate, and GABA addiction sets. The figure 
provides the gene symbols for the intersections of gene sets corresponding to dopamine, 
opiate, and GABA addictions. 
 
Identification and Annotation of Addiction Hotspots on the Human 
Genome 
Unique addiction genes were mapped onto the human genome; 63% of the 
unique set of addiction genes were mapped onto seven genomic hotspot 
regions, all less than 1.5 Mb, the typical length for genetic variation in 
human chromosomes (Figure 3). All these hotspots had at least six or more 
addiction genes. A hypergeometric test was performed to determine the 
statistical significance of all genomic hotspots.  
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Figure 3. Seven addiction hotspots identified on the human genome. Each pie chart 
represents a hotspot, with the size proportional to the total number of genes within the 1- 
to 1.5-Mb window. Three of the hotspots were functionally related exclusively to GABA 
function, whereas four hotspots were mixed in addiction activity. Genes that lie within each 
hotspot were identified through the UCSC Genome Browser. 
 
Three of the seven hotspots contained genes exclusively associated 
GABA addiction, whereas the remaining four hotspots contained genes 
involved in GABA, dopamine, and opiate addictions (Figure 3). For each 
hotspot, we cataloged the co-located genes in the hotspots not yet identified 
as addiction-related. These additional genes are candidates for further 
investigation. Hotspot windows contained 14 to 58 genes, with the number 
of addiction genes ranging from 6 to 19 curated genes located in a hotspot 
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interval. The genes in each hotspot are shown in Figure 4, with those 
already linked to addiction shown in boldface type.  
 
 
Table 1. Addiction genes within hotspots show distinct functional 
classification. The table shows the gene ontology molecular functions and 
biological processes statistically enriched in addiction hotspots (Benjamini 
coefficient <0.03). Annotations in boldface correspond to the addiction 
genes identified within a cluster, not the entire genome region. 
 
The DAVID Gene Ontology data sets were used identify biological 
processes and molecular functions enriched for each hotspot. Table 1 
summarizes the results. The chromosome 4 hotspot for GABA addiction is 
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dominated by metabolic processes and enzymes. A GABA-only hotspot on 
chromosome 6 is crowded by genes involved in nucleosome assembly and 
DNA packaging. The adjacent GABA hotspot is also dominated by DNA 
binding proteins. The genes crowding the mixed hotspot on chromosome 
10 are involved in oxidation reduction and steroid metabolic processes. This 
hotspot has a series of neurological function genes that regulate appetite 
during stress in the brain and neuro-epithelial remodelers. The 
chromosome 11 hotspot contains multiple genes involved in actin 
creation/dynamics, cell development/differentiation, and lipid metabolism, 
in addition to metallothionein genes involved in the metabolism of 
xenobiotics. The chromosome 19 hotspot contains genes mediating 
spermatogenesis, hormone activity, and signaling. It is clear from these 
results that addiction hotspots contain genes with complementary functions.  
 
 
Figure 4. Hotspots participating in acute and chronic alcoholism pathways. The 
alcohol addiction pathway contains genes located in all seven of the addiction hotspots; 
each is colored according to the legend. They participate in post-synaptic processes in 
both acute and chronic alcohol signaling. Additionally, a bar above each gene/component 
in the alcoholism pathway indicates its involvement in dopamine, GABA, or opiate 
addiction. 
 
Addiction-identified genes and their near-neighbor genes from each 
of the seven addiction hotspots were mapped onto KEGG cellular 
pathways. We found consistent participation of hotspot genes in pathways 
involved in neurological signal transmission. Figure 4 illustrates the roles 
that hotspot addiction genes play in canonical addiction pathways. The 
acute and chronic alcoholism pathways are heavily influenced at the post-
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synaptic neuronal cells by genes contained in all seven of the hotspot 
regions. The pathway contains genes that carry out the two major 
mechanisms of addiction regulation: neurotransmission remodeling and 
epigenetic modification. The major pathways involved in dopaminergic and 
morphine addiction also show participation of genes with neurotransmitter 
molecular functions and synaptic transmission biological processes. Figure 
4 illustrates that genes belonging to different hotspots coordinate to function 
in the cellular pathways involved in addiction.  
 
Addiction Hotspots Exhibit Allele Frequency Differences in Human 
Populations 
The presence of addiction hotspots on human chromosomes allowed us to 
identify genomic variation at shared polymorphisms within a hotspot for the 
HapMap populations. We found significant differences in allelic distributions 
both in population comparisons and in population-specific versus neutral 
comparisons. Hotspot polymorphism distributions were then tested against 
the proposed neutral (with respect to selective force) loci with the 
nonparametric Kolmogorov-Smirnov test. To visualize these patterns, we 
generated the heat maps shown in Figure 5 by converting to the –log of the 
P values obtained in pairwise HapMap population comparisons at each 
hotspot. One of the chromosome 6 hotspots (25.7–26.4 Mb) exhibits an 
East Asian similarity in allele frequencies in polymorphisms in comparison 
with non-Asian counterparts.  
 
 
Figure 5. Heat maps of SNP distribution on hotspots show population and 
geographical patterning. Comparisons of the average reference allele frequencies are 
shown for each addiction hotspot across populations by using –log10 of the P values 
obtained from the Kolmogorov-Smirnov test. The variation in neutral regions shows very 
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little demographic patterning, whereas the hotspot located at Chr6: 25.7-26.4 shows 
considerably more regional blocks. 
 
Shared polymorphisms at each addiction hotspot were grouped by 
ethnic geographical origin as Asian, African, or European, with MEX and 
GIH excluded so that we could make comparisons between these 
continental-scale ethnic groups. Figure 6 shows the population comparison 
for polymorphisms along the hotspots. The figure shows that expression 
differs between Asian, African, and European populations for quite a few 
polymorphisms in all the addiction hotspots deciphered in this study; the 
chi-square test (P<0.01) was used in region-level comparisons. Table 2 
identifies significant polymorphisms along the chromosome 6 hotspot (25.7 
Mb–26.4 Mb) for the three continental population comparisons. A large 
portion of these polymorphisms fall within the intron regions of histone 
genes, known to have roles in addiction. However, three others fall within 
the gene SLC17A4, which codes for a sodium phosphate co-transporter in 
the intestinal mucosa. The protein plays an important role in the absorption 
of phosphate from the intestine, and its possible role in addiction is yet to 
be determined. Table 2 also shows five significant intergenic variants 
identified between these populations (dbSNP entries: rs6906576, 
rs6924948, rs7740793, rs9348699, and rs933199).  
 
 
Figure 6. Hotspot SNPs with significantly altered expression in regional population 
subtypes. Significant polymorphisms were found for regional population comparisons 
between African-Asian (N=112), African-European (N=126), and European-Asian (N=122) 
by using the chi-square test with a P value cutoff of 1e-5, as shown by the blue line in the 
figure. The value for the red line cutoff is 5e-8. 
 
Addiction Hotspots show Distant  Genomic Interactions 
Analyses of addiction hotspots based on allele frequency were 
complemented with analyses uncovering linkage to adjacent and distal sites 
in the genome previously identified by GWAS. GWAS3D (M. J. Li et al., 
2013) maps interactions between significant polymorphisms previously 
identified in the “Results” section with annotated genomic interactions culled 
from hundreds of genotype-phenotype studies and GWAS. Polymorphisms 
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were characterized as affecting regulatory pathways and underlying 
disease/trait associations by integrating chromatin state, functional 
genomics, sequence motif, or conservation information given in genetic 
polymorphism inputs. Figure 7 shows a projection of the significant common 
variants between Africans and Europeans onto Yorubans, a sub-Saharan 
African population from Nigeria. In the outer ring, polymorphisms or 
genomic region inputs are identified. The second ring localizes the input 
polymorphism. The thickness of the red lines connecting two 
polymorphisms indicates the strength of local or long-range interactions.  
 
 
Figure 7. Significant SNPs characterized in the Yoruban population show local and 
long-range interactions. Polymorphisms identified as significant in African-European 
comparisons were projected onto the GWAS3D platform. At least six long-range trans-
chromosomal interactions were identified, and numerous local interactions were also 
observed. 
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Discussion 
These results identify for the first time the presence of seven opiate, 
dopamine, and GABA hotspots across the genome. All but two of these 
hotspots share functional annotation between those genes previously 
identified from the addiction literature as participating in addiction 
phenotypes and their co-located gene neighbors. Furthermore, when all 
genes within a hotspot window are mapped onto KEGG pathways, both 
canonical pathways, such as acute alcohol intoxication, and more 
unconventional pathways, such as those involved in systemic lupus, are 
identified. Because addiction phenotypes show ethnic population 
specificity, publicly available polymorphisms from 11 populations were 
assessed at each hotspot location. Three striking ethnicity-based 
signatures arose, at the chromosome 4 hotspot and at one of the 
chromosome 6 hotspots; the Yorubans, a sub-Saharan population of 
Africans, showed differences from all other ethnic populations. Meanwhile, 
at the other chromosome 6 hotspot, East Asian populations showed 
differences from all other surveyed populations. These findings suggest that 
East Asian populations may have both genetic and epigenetic variation for 
alcohol metabolic processes. Genomic polymorphisms were compared with 
those in other GWAS identified studies and found to differ from their 
genomic neighbors in allelic frequencies. Histone gene families are also 
critical to epigenomic processes, representing an additional layer of 
substrate for ethnic differences in human populations. Finally, comparisons 
of significant polymorphisms in this analysis with those identified in other 
GWAS generated a slew of long-range trans-chromosomal linkages to well-
characterized addiction genes, such as the monoamine oxidase A gene 
(MAOA). The enzyme monoamine oxidase catalyzes metabolic reactions 
involving dopamine, norepinephrine, and serotonin. 
Other studies have identified genomic regions of gene set 
enrichment for particularly complex phenotypes (Bradley et al., 2010). 
About 11% of the literature-curated addiction genes formed seven clusters 
of six or more genes within a span of 1.5 Mb, the average distance of 
recombination in humans. This linear genomic distance was chosen to 
attempt to find those regions that are highly likely to be inherited from one 
generation to the next. Three of the seven addiction hotspots (on 
chromosomes 4 and 6) were related exclusively to GABA addiction. The 
rest contained genes that participated in addiction to all three classes of 
illicit substances. Because the hotspot genes also participated in numerous 
metabolic pathways unrelated to addiction, such as the pathways for 
systemic lupus erythematous, viral carcinogenesis, and steroid hormone 
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biosynthesis, we suggest that they may confer susceptibilities to additional 
disorders in long-term substance abusers. The functionally pleiotropic 
nature of these hotspots may help to explain how substance addiction 
creates a spectrum of disorders that are not limited to a particular addictive 
substance (Beitner-Johnson & Nestler, 1991; Schmidt, McGinty, West, & 
Sadri-Vakili, 2013).  
The presence of hotspots on the human genome provides an 
opportunity for the discovery of addiction-related genes. Addiction genes 
accounted for a significant percentage of the total number of genes (>36%) 
in the three hotspots exclusively related to GABA addiction. The four mixed 
hotspots contained many genes not currently linked to addiction. Consider, 
for example, the gene RG9MTD2 in the GABA-only hotspot on chromosome 
4, which codes for an RNA transmethylase expressing an acetaminophen-
binding site. Acetaminophen has been shown to increase feelings of 
intoxication in combination with ethanol in a human cohort and does not 
mitigate subjective feelings of alcohol intoxication (Pickworth, Klein, 
George, & Henningfield, 1992). Additionally, our mixed addiction hotspot 
located at chromosome 19 is adjacent to the killer cell immunoglobulin-like 
receptor (KIR) genomic region. This locus displays extensive diversity 
through polymorphism within individual KIR genes (Hsu, Chida, Geraghty, 
& Dupont, 2002). We speculate that the polymorphisms at this locus could 
promote regulatory changes for the KIR region. Another family of genes with 
potentially important roles, still undefined, are the SLC17A1-4 genes, which 
code for organic ion transporters in a GABA-only hotspot on chromosome 
6. These genes were identified as having storage activity (Reimer & 
Edwards, 2004) for neurotransmitters and therefore might playing crucial 
roles in addiction (Tomkins & Sellers, 2001). 
Addiction hotspots show polymorphism differences in ethnic 
populations. Pooling these populations according to their geographical 
origins (East Asia, Africa, and Europe) allowed a continental perspective of 
the importance of ethnic origin in future analyses of genetic and epigenetic 
interactions. Our analyses found significant population variation at a 
chromosome 6 location, which differentiated HapMap East Asian 
populations from all non-Asian populations. This type of assessment 
provides a potentially potent source of genetic comparisons that could help 
explain phenotype differences between East Asian and non-Asian 
populations. Additionally, the Yoruban (Nigerian) population exhibits unique 
signals of variation at chromosomes 4 and 6. Additional analyses of GWAS 
identifying addiction polymorphisms in the 11 HapMap populations provide 
support for the allele frequency patterns reported in our analysis.  
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The gene contents of GABA-specific addiction hotspots suggest an 
epigenetic role in alcohol addiction (Bali, Im, & Kenny, 2011; Glahn et al., 
2013; Miller, Campbell, & Sweatt, 2008; Ponomarev, 2013). The two 
hotspots on chromosome 6 are highly enriched with histone genes. It is well 
established that the methylation state of histone proteins is directly related 
to whether DNA tracts are turned off or on. Functional annotation shows 
histone involvement in KEGG pathways unrelated to addiction metabolism, 
such as those for systemic lupus, viral carcinogenesis, and transcriptional 
misregulation of cancer. Histone protein modifications through methylation 
have been identified as one of the possible reasons for the diverse 
phenotypes observed in substance-addicted individuals (Bilinski et al., 
2012; Schifano, Li, Christiani, & Lin, 2013; Schmidt et al., 2013). The 
polymorphisms in the histone genes on chromosome 6 may result in 
alternate epigenetic modifications among ethnic populations, a result 
previously seen in other data sets (Fraser, Lam, Neumann, & Kobor, 2012). 
Moreover, our GWAS3D analyses found that the chromosome 6 
polymorphisms identified as significant in our cross-population 
assessments were also involved in local and trans-chromosomal 
interactions. Potential links between hotspots, addiction genes, and 
differences in polymorphism frequency merit further investigation. This 
analysis leverages a systems biology framework to incorporate disparate 
sources of data. Currently, data such as those garnered from the human 
HapMap project, ClinVar, GWAS Central, and dbSNP provide rich source 
materials for the creation of genetic predictive models to identify at-risk 
communities and ethnic populations within the United States. A clear 
challenge continues to be the integration of sociological and environmental 
data with existing genomic data analyses. Nevertheless, this approach 
provides a foundation for expanding interdisciplinary data analysis, so that 
greater inferences can be made in understanding complex phenotypes, 
such as those of opiate, dopamine, and alcohol substance addiction; it also 
has the potential to accelerate the development of precision medicine 
models for vulnerable and at-risk groups.
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